171 related articles for article (PubMed ID: 21671473)
41. Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.
Rosenberg LU; Magnusson C; Lindström E; Wedrén S; Hall P; Dickman PW
Breast Cancer Res; 2006; 8(1):R11. PubMed ID: 16507159
[TBL] [Abstract][Full Text] [Related]
42. Menopausal symptoms and risk of coronary heart disease in middle-aged women: A nationwide population-based cohort study.
Huang CH; Li CL; Kor CT; Chang CC
PLoS One; 2018; 13(10):e0206036. PubMed ID: 30335825
[TBL] [Abstract][Full Text] [Related]
43. Menopausal hormone therapy and colorectal cancer: a linkage between nationwide registries in Norway.
Botteri E; Støer NC; Sakshaug S; Graff-Iversen S; Vangen S; Hofvind S; de Lange T; Bagnardi V; Ursin G; Weiderpass E
BMJ Open; 2017 Nov; 7(11):e017639. PubMed ID: 29146641
[TBL] [Abstract][Full Text] [Related]
44. Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.
Javed AA; Mayhew AJ; Shea AK; Raina P
JAMA Netw Open; 2019 Aug; 2(8):e1910154. PubMed ID: 31461147
[TBL] [Abstract][Full Text] [Related]
45. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin.
Pearce CL; Chung K; Pike MC; Wu AH
Cancer; 2009 Feb; 115(3):531-9. PubMed ID: 19127543
[TBL] [Abstract][Full Text] [Related]
46. Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study.
Suhrke P; Zahl PH
Cancer Med; 2015 Aug; 4(8):1303-8. PubMed ID: 25991514
[TBL] [Abstract][Full Text] [Related]
47. Menopausal hormone therapies and risk of colorectal cancer: a Swedish matched-cohort study.
Liu Q; Simin J; Debelius J; Fall K; Sadr-Azodi O; Engstrand L; Williams C; Brusselaers N
Aliment Pharmacol Ther; 2021 Jun; 53(11):1216-1225. PubMed ID: 33857339
[TBL] [Abstract][Full Text] [Related]
48. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Main C; Knight B; Moxham T; Gabriel Sanchez R; Sanchez Gomez LM; Roqué i Figuls M; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Apr; (4):CD002229. PubMed ID: 23633307
[TBL] [Abstract][Full Text] [Related]
49. Estrogen and combined estrogen-progestogen therapy in the menopause and breast cancer.
La Vecchia C
Breast; 2004 Dec; 13(6):515-8. PubMed ID: 15563861
[TBL] [Abstract][Full Text] [Related]
50. The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy.
Løkkegaard E; Jovanovic Z; Heitmann BL; Keiding N; Ottesen B; Pedersen AT
Maturitas; 2006 Jan; 53(2):226-33. PubMed ID: 15955642
[TBL] [Abstract][Full Text] [Related]
51. Menopause and postmenopausal hormone therapy and risk of hearing loss.
Curhan SG; Eliassen AH; Eavey RD; Wang M; Lin BM; Curhan GC
Menopause; 2017 Sep; 24(9):1049-1056. PubMed ID: 28486246
[TBL] [Abstract][Full Text] [Related]
52. Female hormone utilisation and risk of hepatocellular carcinoma.
Tavani A; Negri E; Parazzini F; Franceschi S; La Vecchia C
Br J Cancer; 1993 Mar; 67(3):635-7. PubMed ID: 8382515
[TBL] [Abstract][Full Text] [Related]
53. Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study.
Clague J; Reynolds P; Sullivan-Halley J; Ma H; Lacey JV; Henderson KD; Ursin G; West D; Chang S; Delclos GL; Du XL; Forman MR; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2011 Mar; 20(3):560-4. PubMed ID: 21266521
[TBL] [Abstract][Full Text] [Related]
54. A meta-analysis of hormone replacement therapy and colon cancer in women.
Hébert-Croteau N
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):653-9. PubMed ID: 9718216
[TBL] [Abstract][Full Text] [Related]
55. A Nested Case-Control Study on Plasma Vitamin E and Risk of Cancer: Evidence of Effect Modification by Selenium.
Wang J; Guo H; Lin T; Song Y; Zhang H; Wang B; Zhang Y; Li J; Huo Y; Wang X; Qin X; Xu X
J Acad Nutr Diet; 2019 May; 119(5):769-781. PubMed ID: 30713028
[TBL] [Abstract][Full Text] [Related]
56. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
[TBL] [Abstract][Full Text] [Related]
57. Serum estrogen and SHBG levels and breast cancer incidence among users and never users of hormone replacement therapy.
Würtz AM; Tjønneland A; Christensen J; Dragsted LO; Aarestrup J; Kyrø C; Overvad K; Olsen A
Cancer Causes Control; 2012 Oct; 23(10):1711-20. PubMed ID: 22926300
[TBL] [Abstract][Full Text] [Related]
58. Menopausal hormone therapy.
Bhavnani BR; Strickler RC
J Obstet Gynaecol Can; 2005 Feb; 27(2):137-62. PubMed ID: 15937590
[TBL] [Abstract][Full Text] [Related]
59. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
60. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).
Blümel JE; Chedraui P; Barón G; Benítez Z; Flores D; Espinoza MT; Gomez G; González E; Hernández L; Lima S; Martino M; Montaño A; Monterrosa A; Mostajo D; Ojeda E; Onatra W; Robles C; Saavedra J; Sánchez H; Tserotas K; Vallejo MS; Vallejo C;
Climacteric; 2014 Aug; 17(4):433-41. PubMed ID: 24443950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
